Last data update: Nov 11, 2024. (Total: 48109 publications since 2009)
Records 1-6 (of 6 Records) |
Query Trace: Knight NW[original query] |
---|
Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020 (preprint)
Shah MM , Salvatore PP , Ford L , Kamitani E , Whaley MJ , Mitchell K , Currie DW , Morgan CN , Segaloff HE , Lecher S , Somers T , Van Dyke ME , Bigouette JP , Delaney A , DaSilva J , O'Hegarty M , Boyle-Estheimer L , Abdirizak F , Karpathy SE , Meece J , Ivanic L , Goffard K , Gieryn D , Sterkel A , Bateman A , Kahrs J , Langolf K , Zochert T , Knight NW , Hsu CH , Kirking HL , Tate JE . medRxiv 2021 2021.04.05.21254834 Repeating the BinaxNOW antigen test for SARS-CoV-2 by two groups of readers within 30 minutes resulted in high concordance (98.9%) in 2,110 encounters. BinaxNOW test sensitivity was 77.2% (258/334) compared to real-time reverse transcription-polymerase chain reaction. Repeating antigen testing on the same day did not significantly improve test sensitivity while specificity remained high.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Centers for Disease Control and Prevention.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy. See e.g., 45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. 241(d); 5 U.S.C. 552a; 44 U.S.C. 3501 et seq.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon reasonable request. |
Public health actions to control measles among Afghan evacuees during Operation Allies Welcome - United States, September-November 2021
Masters NB , Mathis AD , Leung J , Raines K , Clemmons NS , Miele K , Balajee SA , Lanzieri TM , Marin M , Christensen DL , Clarke KR , Cruz MA , Gallagher K , Gearhart S , Gertz AM , Grady-Erickson O , Habrun CA , Kim G , Kinzer MH , Miko S , Oberste MS , Petras JK , Pieracci EG , Pray IW , Rosenblum HG , Ross JM , Rothney EE , Segaloff HE , Shepersky LV , Skrobarcek KA , Stadelman AM , Sumner KM , Waltenburg MA , Weinberg M , Worrell MC , Bessette NE , Peake LR , Vogt MP , Robinson M , Westergaard RP , Griesser RH , Icenogle JP , Crooke SN , Bankamp B , Stanley SE , Friedrichs PA , Fletcher LD , Zapata IA , Wolfe HO , Gandhi PH , Charles JY , Brown CM , Cetron MS , Pesik N , Knight NW , Alvarado-Ramy F , Bell M , Talley LE , Rotz LD , Rota PA , Sugerman DE , Gastañaduy PA . MMWR Morb Mortal Wkly Rep 2022 71 (17) 592-596 On August 29, 2021, the United States government oversaw the emergent establishment of Operation Allies Welcome (OAW), led by the U.S. Department of Homeland Security (DHS) and implemented by the U.S. Department of Defense (DoD) and U.S. Department of State (DoS), to safely resettle U.S. citizens and Afghan nationals from Afghanistan to the United States. Evacuees were temporarily housed at several overseas locations in Europe and Asia* before being transported via military and charter flights through two U.S. international airports, and onward to eight U.S. military bases,(†) with hotel A used for isolation and quarantine of persons with or exposed to certain infectious diseases.(§) On August 30, CDC issued an Epi-X notice encouraging public health officials to maintain vigilance for measles among Afghan evacuees because of an ongoing measles outbreak in Afghanistan (25,988 clinical cases reported nationwide during January-November 2021) (1) and low routine measles vaccination coverage (66% and 43% for the first and second doses, respectively, in 2020) (2). |
Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020.
Shah MM , Salvatore PP , Ford L , Kamitani E , Whaley MJ , Kaitlin M , Currie DW , Morgan CN , Segaloff HE , Lecher S , Somers T , Van Dyke ME , Bigouette JP , Delaney A , DaSilva J , O'Hegarty M , Boyle-Estheimer L , Abdirizak F , Karpathy SE , Meece J , Ivanic L , Goffard K , Gieryn D , Sterkel A , Bateman A , Kahrs J , Langolf K , Zochert T , Knight NW , Hsu CH , Kirking HL , Tate JE . Clin Infect Dis 2021 73 S54-S57 Repeating the BinaxNOW antigen test for SARS-CoV-2 by two groups of readers within 30 minutes resulted in high concordance (98.9%) in 2,110 encounters. BinaxNOW test sensitivity was 77.2% (258/334) compared to real-time reverse transcription-polymerase chain reaction. Same day antigen testing did not significantly improve test sensitivity while specificity remained high. |
Lessons learned in global health security implementation
Moolenaar RL , Cassell CH , Knight NW . Health Secur 2020 18 S4-s7 If you want to travel fast, go alone; if you want to travel far, go together. | | —African Proverb | | The US Centers for Disease Control and Prevention's (CDC) Strategic Framework articulates 3 agency priorities: secure global health and America's preparedness, eliminate disease, and end epidemics.1 After 5 years of implementing the Global Health Security Agenda (GHSA),2-5 we have learned many lessons. While more work remains in global health security, documenting lessons learned is imperative to provide the evidence base for the next steps in global health security implementation. The theme of this Supplement to Health Security is: “what works—lessons learned in global health security implementation.” The information shared in this compilation is intended to add value to the efforts of everyone interested and engaged in health security. |
Building global health security capacity: The role for implementation science
Morgan J , Kennedy ED , Pesik N , Angulo FJ , Craig AS , Knight NW , Bunnell RE . Health Secur 2018 16 S5-s7 Since the launch of the Global Health Security Agenda (GHSA) in 2014,1-3 many countries around the world have accelerated efforts to achieve compliance with the World Health Organization's (WHO) International Health Regulations (IHR 2005) to build their capacities to detect, assess, and report public health events.4 WHO approved a standardized Joint External Evaluation (JEE) tool in February 2016 that provides a framework for assessing a country's gaps and progress toward IHR 2005 implementation.5,6 By October 2018, more than 86 countries in 6 regions had completed a JEE.7 Based on JEE scores and recommended priority actions for improvement, multiple countries, in collaboration with technical partners such as the US Centers for Disease Control and Prevention (CDC), are actively working to build their capacities and strengthen core systems to prevent, detect, and respond to public health threats. |
Global health security implementation: Expanding the evidence base
Kennedy ED , Morgan J , Knight NW . Health Secur 2018 16 S1-s4 In recent years, the world has seen a series of alarming public health emergencies across the globe that have resulted in thousands of lives lost and billions of dollars in economic losses.1-8 The frequency and impact of these emergencies, coupled with the ease and reach of international travel and rapidly expanding global commerce and trade, have raised the urgency for all countries to prepare for future emergencies. As we write this piece, the second Ebola outbreak in 2018 in the Democratic Republic of the Congo (DRC) is accelerating in a resource-limited environment and armed conflict zone. This outbreak represents another test of the global health community's ability to contain this threat and prevent global spread.9 | | The severe acute respiratory syndrome (SARS) outbreak in 2002-03 highlighted the need for updated international guidance for cooperation between countries and the need for all countries to develop core capacities to detect, report, and respond to infectious disease threats at the source.10,11 The impact of SARS highlighted the importance of improving global health security and accelerated the adoption of the revised International Health Regulations (IHR 2005). By 2007, all 196 World Health Organization (WHO) member states had committed to reaching compliance with these regulations by 2012.12 However, more than two-thirds of countries had failed to meet these standards by 2014.13 |
- Page last reviewed:Feb 1, 2024
- Page last updated:Nov 11, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure